NO20033305D0 - Nytt filmbelegg - Google Patents
Nytt filmbeleggInfo
- Publication number
- NO20033305D0 NO20033305D0 NO20033305A NO20033305A NO20033305D0 NO 20033305 D0 NO20033305 D0 NO 20033305D0 NO 20033305 A NO20033305 A NO 20033305A NO 20033305 A NO20033305 A NO 20033305A NO 20033305 D0 NO20033305 D0 NO 20033305D0
- Authority
- NO
- Norway
- Prior art keywords
- film coating
- film
- core
- coating composition
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100200A SE0100200D0 (sv) | 2001-01-24 | 2001-01-24 | New film coating |
PCT/SE2002/000103 WO2002058677A1 (en) | 2001-01-24 | 2002-01-22 | New film coating |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20033305D0 true NO20033305D0 (no) | 2003-07-22 |
NO20033305L NO20033305L (no) | 2003-07-22 |
Family
ID=20282714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20033305A NO20033305L (no) | 2001-01-24 | 2003-07-22 | Nytt filmbelegg |
Country Status (22)
Country | Link |
---|---|
US (1) | US7959947B2 (no) |
EP (1) | EP1355635B1 (no) |
JP (1) | JP4303471B2 (no) |
KR (1) | KR100874582B1 (no) |
CN (1) | CN1218692C (no) |
AT (1) | ATE285229T1 (no) |
AU (1) | AU2002225573B2 (no) |
BR (1) | BR0206515A (no) |
CA (1) | CA2433530A1 (no) |
DE (2) | DE60202351T2 (no) |
DK (1) | DK1355635T3 (no) |
ES (1) | ES2233804T3 (no) |
HK (1) | HK1063432A1 (no) |
IL (2) | IL156623A0 (no) |
MX (1) | MXPA03006419A (no) |
NO (1) | NO20033305L (no) |
NZ (1) | NZ526792A (no) |
PT (1) | PT1355635E (no) |
SE (1) | SE0100200D0 (no) |
SI (1) | SI1355635T1 (no) |
WO (1) | WO2002058677A1 (no) |
ZA (1) | ZA200305457B (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0100200D0 (sv) | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
BR0206441A (pt) * | 2001-12-19 | 2003-12-30 | Astrazeneca Ab | Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica de liberação modificada, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula e uma formulação |
US8323692B2 (en) | 2002-02-21 | 2012-12-04 | Valeant International Bermuda | Controlled release dosage forms |
SI1476138T1 (sl) * | 2002-02-21 | 2012-07-31 | Valeant Internat Barbados Srl | Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola |
SE0201110D0 (sv) * | 2002-04-12 | 2002-04-12 | Astrazeneca Ab | New film coating |
SE0202353D0 (sv) * | 2002-08-01 | 2002-08-01 | Astrazeneca Ab | New film coating |
AU2003282375A1 (en) * | 2003-02-05 | 2004-08-30 | Ipca Laboratories Limited | Pharmaceutical compositions and process of production thereof |
NZ547284A (en) * | 2003-10-31 | 2009-12-24 | Hexal Ag | Pharmaceutical agent-containing formulation comprising a coating of a film forming polymer |
TWI350762B (en) | 2004-02-12 | 2011-10-21 | Euro Celtique Sa | Particulates |
GB0403098D0 (en) | 2004-02-12 | 2004-03-17 | Euro Celtique Sa | Extrusion |
EP2801354B1 (en) | 2004-10-08 | 2017-02-08 | Forward Pharma A/S | Controlled release pharmaceutical compositions comprising a fumaric acid ester |
US20120034274A1 (en) * | 2009-01-09 | 2012-02-09 | Forward Pharma A/S | Pharmaceutical composition comprising one or more fumaric acid esters |
KR101699912B1 (ko) | 2009-01-09 | 2017-01-25 | 포워드 파마 에이/에스 | 1종 이상의 푸마르산 에스테르를 침식 매트릭스에 함유하는 제제 |
US20100303920A1 (en) * | 2009-05-27 | 2010-12-02 | Johan Hjartstam | Aqueous Film Coating Composition / 841 |
US20110229564A1 (en) * | 2010-03-22 | 2011-09-22 | Amneal Pharmaceuticals, L.L.C. | Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof |
CA2870134C (en) | 2012-05-02 | 2020-04-28 | Capsugel France SAS | Aqueous dispersions of hydroxypropyl methylcellulose acetate succinate (hpmcas) |
WO2014124700A1 (en) | 2013-02-13 | 2014-08-21 | Evonik Industries Ag | Multiparticulate pharmaceutical composition comprising a multitude of two kinds of pellets |
EP3065720A1 (en) | 2013-11-04 | 2016-09-14 | Capsugel Belgium NV | Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole |
CN105085778B (zh) * | 2014-04-22 | 2018-11-16 | 广东华润涂料有限公司 | 用于缓释功能成分的涂料组合物用水性胶乳、其制备方法以及应用 |
DK3265126T3 (da) | 2015-03-03 | 2021-09-13 | Saniona As | Kombinationsformulering af tesofensin og metoprolol |
EP3478792B1 (en) * | 2016-06-30 | 2023-12-13 | Beckman Coulter, Inc. | Chemiluminescent substrates |
US10744087B2 (en) | 2018-03-22 | 2020-08-18 | Incarda Therapeutics, Inc. | Method to slow ventricular rate |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB878234A (en) | 1958-12-18 | 1961-09-27 | Roehm & Haas Gmbh | Pharmaceutical coating compositions |
DE1228757B (de) | 1962-06-28 | 1966-11-17 | Haessle Ab | Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen |
US3341338A (en) | 1965-05-28 | 1967-09-12 | Union Carbide Corp | Polysiloxane polish formulations |
DE2031871C3 (de) | 1970-06-27 | 1974-06-27 | Roehm Gmbh, 6100 Darmstadt | Überzugsmasse für Arzneiformen |
US4330338A (en) | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
US4353887A (en) * | 1979-08-16 | 1982-10-12 | Ciba-Geigy Corporation | Divisible tablet having controlled and delayed release of the active substance |
US4916171A (en) | 1984-07-25 | 1990-04-10 | Rohm And Haas Company | Polymers comprising alkali-insoluble core/alkali-soluble shell and copositions thereof |
SE8404467D0 (sv) | 1984-09-06 | 1984-09-06 | Ferrosan Ab | Controlled-release medical preparations |
CH666405A5 (de) | 1985-06-24 | 1988-07-29 | Ciba Geigy Ag | Feste, haltbare darreichungsformen mit elastischem filmueberzug. |
US5246714A (en) | 1985-10-11 | 1993-09-21 | Aktiebolaget Hassle | Drug preparation |
SE455836B (sv) | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
SE450087B (sv) | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
US4975283A (en) | 1985-12-12 | 1990-12-04 | Bristol-Myers Squibb Company | Stabilized enteric coated aspirin granules and process for preparation |
US4800087A (en) | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
US4871546A (en) | 1987-06-29 | 1989-10-03 | Sandoz Pharm. Corp. | Gastrointestinal protective coating formulations |
EP0313845A1 (en) | 1987-09-29 | 1989-05-03 | Warner-Lambert Company | Stabilization of enteric coated dosage form |
FR2655266B1 (fr) | 1989-12-05 | 1992-04-03 | Smith Kline French Lab | Compositions pharmaceutiques a base de cimetidine. |
JP2558396B2 (ja) | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
GB9200607D0 (en) | 1992-01-13 | 1992-03-11 | Ethical Pharma Ltd | Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
US5656296A (en) * | 1992-04-29 | 1997-08-12 | Warner-Lambert Company | Dual control sustained release drug delivery systems and methods for preparing same |
US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
DK0621032T3 (da) * | 1993-04-23 | 2000-10-23 | Novartis Ag | Lægemiddelform med reguleret afgivelse |
US5484597A (en) * | 1993-07-30 | 1996-01-16 | Chesebrough-Pond's Usa Co. | Clear hydroalcholic cosmetic microemulsions |
FR2725623A1 (fr) | 1994-10-18 | 1996-04-19 | Flamel Tech Sa | Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os |
DE4444051A1 (de) | 1994-12-10 | 1996-06-13 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
US5948438A (en) * | 1995-01-09 | 1999-09-07 | Edward Mendell Co., Inc. | Pharmaceutical formulations having improved disintegration and/or absorptivity |
US5871776A (en) * | 1995-01-31 | 1999-02-16 | Mehta; Atul M. | Controlled-release nifedipine |
DE69713948D1 (de) * | 1996-04-23 | 2002-08-22 | Janssen Pharmaceutica Nv | Rasch-freisetzende pH-unabhängige feste Dosisformen enthaltend Cisaprid |
US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
US6627223B2 (en) | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
SE0100200D0 (sv) | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
BR0206441A (pt) * | 2001-12-19 | 2003-12-30 | Astrazeneca Ab | Composição de revestimento de pelìcula, revestimento de pelìcula cobrindo um núcleo farmacêutico, formulação farmacêutica de liberação modificada, e, processos para preparar uma composição de revestimento de pelìcula, um revestimento de pelìcula e uma formulação |
SE0201110D0 (sv) | 2002-04-12 | 2002-04-12 | Astrazeneca Ab | New film coating |
SE0202353D0 (sv) * | 2002-08-01 | 2002-08-01 | Astrazeneca Ab | New film coating |
-
2001
- 2001-01-24 SE SE0100200A patent/SE0100200D0/xx unknown
-
2002
- 2002-01-22 MX MXPA03006419A patent/MXPA03006419A/es active IP Right Grant
- 2002-01-22 DE DE60202351T patent/DE60202351T2/de not_active Expired - Lifetime
- 2002-01-22 BR BR0206515-0A patent/BR0206515A/pt not_active IP Right Cessation
- 2002-01-22 NZ NZ526792A patent/NZ526792A/xx unknown
- 2002-01-22 EP EP02715942A patent/EP1355635B1/en not_active Expired - Lifetime
- 2002-01-22 AT AT02715942T patent/ATE285229T1/de active
- 2002-01-22 PT PT02715942T patent/PT1355635E/pt unknown
- 2002-01-22 WO PCT/SE2002/000103 patent/WO2002058677A1/en active IP Right Grant
- 2002-01-22 US US10/466,099 patent/US7959947B2/en not_active Expired - Fee Related
- 2002-01-22 CA CA002433530A patent/CA2433530A1/en not_active Abandoned
- 2002-01-22 ES ES02715942T patent/ES2233804T3/es not_active Expired - Lifetime
- 2002-01-22 DE DE20220901U patent/DE20220901U1/de not_active Expired - Lifetime
- 2002-01-22 DK DK02715942T patent/DK1355635T3/da active
- 2002-01-22 IL IL15662302A patent/IL156623A0/xx active IP Right Grant
- 2002-01-22 JP JP2002559011A patent/JP4303471B2/ja not_active Expired - Fee Related
- 2002-01-22 AU AU2002225573A patent/AU2002225573B2/en not_active Ceased
- 2002-01-22 CN CNB028040813A patent/CN1218692C/zh not_active Expired - Fee Related
- 2002-01-22 KR KR1020037009573A patent/KR100874582B1/ko not_active IP Right Cessation
- 2002-01-22 SI SI200230081T patent/SI1355635T1/xx unknown
-
2003
- 2003-06-24 IL IL156623A patent/IL156623A/en not_active IP Right Cessation
- 2003-07-15 ZA ZA200305457A patent/ZA200305457B/en unknown
- 2003-07-22 NO NO20033305A patent/NO20033305L/no not_active Application Discontinuation
-
2004
- 2004-08-19 HK HK04106220A patent/HK1063432A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2002058677A1 (en) | 2002-08-01 |
IL156623A0 (en) | 2004-01-04 |
SE0100200D0 (sv) | 2001-01-24 |
BR0206515A (pt) | 2004-02-17 |
DE20220901U1 (de) | 2004-06-17 |
EP1355635B1 (en) | 2004-12-22 |
HK1063432A1 (en) | 2004-12-31 |
ATE285229T1 (de) | 2005-01-15 |
CN1487828A (zh) | 2004-04-07 |
KR20030070122A (ko) | 2003-08-27 |
SI1355635T1 (en) | 2005-06-30 |
PT1355635E (pt) | 2005-04-29 |
NZ526792A (en) | 2004-12-24 |
AU2002225573B2 (en) | 2006-09-07 |
NO20033305L (no) | 2003-07-22 |
US20040058001A1 (en) | 2004-03-25 |
ES2233804T3 (es) | 2005-06-16 |
JP4303471B2 (ja) | 2009-07-29 |
CA2433530A1 (en) | 2002-08-01 |
JP2004522741A (ja) | 2004-07-29 |
ZA200305457B (en) | 2004-10-15 |
MXPA03006419A (es) | 2003-10-15 |
CN1218692C (zh) | 2005-09-14 |
US7959947B2 (en) | 2011-06-14 |
IL156623A (en) | 2007-12-03 |
EP1355635A1 (en) | 2003-10-29 |
KR100874582B1 (ko) | 2008-12-16 |
DK1355635T3 (da) | 2005-03-29 |
DE60202351T2 (de) | 2005-12-01 |
DE60202351D1 (de) | 2005-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20033305D0 (no) | Nytt filmbelegg | |
WO2002072033A3 (en) | Chronotherapeutic dosage forms containing glucocorticosteroid | |
CA2290531A1 (en) | Pharmaceutical formulation of omeprazole | |
SE9803772D0 (sv) | Pharmaceutical formulation | |
IT1289160B1 (it) | Compressa farmaceutica completamente rivestita per il rilascio controllato di principi attivi che presentano problemi di | |
ATE334663T1 (de) | Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe | |
ATE184196T1 (de) | Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe | |
MY129350A (en) | Aripiprazole oral solution | |
WO2005027843A3 (en) | Chronotherapeutic dosage forms | |
DE60042972D1 (de) | Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung | |
NO20031409D0 (no) | Ionestyrkeuavhengig farmasöytiske preparat med langvarig frigivelse | |
BR0207066A (pt) | Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles | |
EP1245562A4 (en) | ALCOHOLS 5-THIA- "OMEGA" - (PHENYL SUBSTITUTED) - PROSTAGLANDIN E, PROCESS FOR THE PREPARATION OF SUCH ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE ALCOHOLS AS ACTIVE INGREDIENT. | |
WO2003035043A3 (en) | Pharmaceutical formulation comprising more than 15% tamoxifen | |
AU2001274000A1 (en) | Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them | |
DK1275383T3 (da) | "Modified release" farmaceutisk komposition, der indeholder Bupropion HCI som aktivt stof | |
CA2440710A1 (en) | Medicine of post-traumatic stress disorder | |
HUP0204150A3 (en) | Monohydrate of cis-lithium-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylate, process for its preparation and pharmaceutical compositions containing the same | |
WO2002100346A3 (en) | (r, r'),(r',s')-amphetaminil, compositions and uses thereof | |
ITMI942223A0 (it) | Formulazioni farmaceutiche per il rilascio controllato e costante di principi attivi costituite da matrici idrofile parzialmente rivestite da film semipermeabili o permeabili applicati per immersione o spruzzo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |